APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dog Prescription Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Dog Prescription Drugs Market Outlook and Growth Opportunities 2026

22 December 2025193 pages

Choose your research edition.

Industry ResearchDog Prescription Drugs Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Dog Prescription Drugs Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Dog Prescription Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dog Prescription Drugs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Dog Prescription Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Dog Prescription Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Dog Prescription Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dog Prescription Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dog Prescription Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Dog Prescription Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Dog Prescription Drugs market include Zoetis, Virbac, Vetoquinol, Ourofino Saude Animal, MSD Animal Health, Elanco Animal Health, Dechra, Ceva Sante Animale and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Dog Prescription Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dog Prescription Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dog Prescription Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dog Prescription Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Dog Prescription Drugs Segment by Company

Zoetis

Virbac

Vetoquinol

Ourofino Saude Animal

MSD Animal Health

Elanco Animal Health

Dechra

Ceva Sante Animale

Boehringer Ingelheim

Animalcare Group

Dog Prescription Drugs Segment by Type

Oral Type

Spray Type

Smear Type

Injection Type

Dog Prescription Drugs Segment by Application

Hospital

Clinic

Others

Dog Prescription Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Dog Prescription Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Dog Prescription Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Dog Prescription Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Dog Prescription Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dog Prescription Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dog Prescription Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dog Prescription Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dog Prescription Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Dog Prescription Drugs industry.

Chapter 3: Detailed analysis of Dog Prescription Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Dog Prescription Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Dog Prescription Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Dog Prescription Drugs Industry Trends Table 2. Dog Prescription Drugs Industry Drivers Table 3. Dog Prescription Drugs Industry Opportunities and Challenges Table 4. Dog Prescription Drugs Industry Restraints Table 5. Global Dog Prescription Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Dog Prescription Drugs Revenue Share by Company (2021-2026) Table 7. Global Dog Prescription Drugs Sales Volume by Company (k units) & (2021-2026) Table 8. Global Dog Prescription Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Dog Prescription Drugs Average Price (US$/unit) of Company (2021-2026) Table 10. Global Dog Prescription Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Dog Prescription Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Dog Prescription Drugs Company, Product Type & Application Table 13. Global Dog Prescription Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Dog Prescription Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Oral Type Table 18. Significant Companies of Spray Type Table 19. Significant Companies of Smear Type Table 20. Significant Companies of Injection Type Table 21. Global Dog Prescription Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Dog Prescription Drugs Sales Volume by Type (2021-2026) & (k units) Table 23. Global Dog Prescription Drugs Sales Volume by Type (2027-2032) & (k units) Table 24. Global Dog Prescription Drugs Sales Volume Share by Type (2021-2026) Table 25. Global Dog Prescription Drugs Sales Volume Share by Type (2027-2032) Table 26. Global Dog Prescription Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Dog Prescription Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Dog Prescription Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Dog Prescription Drugs Sales Value Share by Type (2021-2026) Table 30. Global Dog Prescription Drugs Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospital Table 32. Significant Companies of Clinic Table 33. Significant Companies of Others Table 34. Global Dog Prescription Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Dog Prescription Drugs Sales Volume by Application (2021-2026) & (k units) Table 36. Global Dog Prescription Drugs Sales Volume by Application (2027-2032) & (k units) Table 37. Global Dog Prescription Drugs Sales Volume Share by Application (2021-2026) Table 38. Global Dog Prescription Drugs Sales Volume Share by Application (2027-2032) Table 39. Global Dog Prescription Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Dog Prescription Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Dog Prescription Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Dog Prescription Drugs Sales Value Share by Application (2021-2026) Table 43. Global Dog Prescription Drugs Sales Value Share by Application (2027-2032) Table 44. Global Dog Prescription Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Dog Prescription Drugs Sales by Region (2021-2026) & (k units) Table 46. Global Dog Prescription Drugs Sales Market Share by Region (2021-2026) Table 47. Global Dog Prescription Drugs Sales by Region (2027-2032) & (k units) Table 48. Global Dog Prescription Drugs Sales Market Share by Region (2027-2032) Table 49. Global Dog Prescription Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Dog Prescription Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Dog Prescription Drugs Sales Value Share by Region (2021-2026) Table 52. Global Dog Prescription Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Dog Prescription Drugs Sales Value Share by Region (2027-2032) Table 54. Global Dog Prescription Drugs Market Average Price (US$/unit) by Region (2021-2026) Table 55. Global Dog Prescription Drugs Market Average Price (US$/unit) by Region (2027-2032) Table 56. Global Dog Prescription Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Global Dog Prescription Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Dog Prescription Drugs Sales by Country (2021-2026) & (k units) Table 59. Global Dog Prescription Drugs Sales Market Share by Country (2021-2026) Table 60. Global Dog Prescription Drugs Sales by Country (2027-2032) & (k units) Table 61. Global Dog Prescription Drugs Sales Market Share by Country (2027-2032) Table 62. Global Dog Prescription Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Dog Prescription Drugs Sales Value Market Share by Country (2021-2026) Table 64. Global Dog Prescription Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Dog Prescription Drugs Sales Value Market Share by Country (2027-2032) Table 66. Zoetis Company Information Table 67. Zoetis Business Overview Table 68. Zoetis Dog Prescription Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Zoetis Dog Prescription Drugs Product Portfolio Table 70. Zoetis Recent Development Table 71. Virbac Company Information Table 72. Virbac Business Overview Table 73. Virbac Dog Prescription Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Virbac Dog Prescription Drugs Product Portfolio Table 75. Virbac Recent Development Table 76. Vetoquinol Company Information Table 77. Vetoquinol Business Overview Table 78. Vetoquinol Dog Prescription Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Vetoquinol Dog Prescription Drugs Product Portfolio Table 80. Vetoquinol Recent Development Table 81. Ourofino Saude Animal Company Information Table 82. Ourofino Saude Animal Business Overview Table 83. Ourofino Saude Animal Dog Prescription Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Ourofino Saude Animal Dog Prescription Drugs Product Portfolio Table 85. Ourofino Saude Animal Recent Development Table 86. MSD Animal Health Company Information Table 87. MSD Animal Health Business Overview Table 88. MSD Animal Health Dog Prescription Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. MSD Animal Health Dog Prescription Drugs Product Portfolio Table 90. MSD Animal Health Recent Development Table 91. Elanco Animal Health Company Information Table 92. Elanco Animal Health Business Overview Table 93. Elanco Animal Health Dog Prescription Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Elanco Animal Health Dog Prescription Drugs Product Portfolio Table 95. Elanco Animal Health Recent Development Table 96. Dechra Company Information Table 97. Dechra Business Overview Table 98. Dechra Dog Prescription Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Dechra Dog Prescription Drugs Product Portfolio Table 100. Dechra Recent Development Table 101. Ceva Sante Animale Company Information Table 102. Ceva Sante Animale Business Overview Table 103. Ceva Sante Animale Dog Prescription Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Ceva Sante Animale Dog Prescription Drugs Product Portfolio Table 105. Ceva Sante Animale Recent Development Table 106. Boehringer Ingelheim Company Information Table 107. Boehringer Ingelheim Business Overview Table 108. Boehringer Ingelheim Dog Prescription Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Boehringer Ingelheim Dog Prescription Drugs Product Portfolio Table 110. Boehringer Ingelheim Recent Development Table 111. Animalcare Group Company Information Table 112. Animalcare Group Business Overview Table 113. Animalcare Group Dog Prescription Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Animalcare Group Dog Prescription Drugs Product Portfolio Table 115. Animalcare Group Recent Development Table 116. Key Raw Materials Table 117. Raw Materials Key Suppliers Table 118. Dog Prescription Drugs Distributors List Table 119. Dog Prescription Drugs Customers List Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Dog Prescription Drugs Product Image Figure 2. Global Dog Prescription Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dog Prescription Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Dog Prescription Drugs Sales (2021-2032) & (k units) Figure 5. Global Dog Prescription Drugs Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Dog Prescription Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Oral Type Image Figure 10. Spray Type Image Figure 11. Smear Type Image Figure 12. Injection Type Image Figure 13. Global Dog Prescription Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Dog Prescription Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Dog Prescription Drugs Sales Volume Share by Type (2021-2032) Figure 16. Global Dog Prescription Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Dog Prescription Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Dog Prescription Drugs Sales Value Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Clinic Image Figure 21. Others Image Figure 22. Global Dog Prescription Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Dog Prescription Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Dog Prescription Drugs Sales Volume Share by Application (2021-2032) Figure 25. Global Dog Prescription Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Dog Prescription Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Dog Prescription Drugs Sales Value Share by Application (2021-2032) Figure 28. Global Dog Prescription Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global Dog Prescription Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Dog Prescription Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Dog Prescription Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Dog Prescription Drugs Sales Value (2021-2032) & (US$ Million) Figure 33. North America Dog Prescription Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Dog Prescription Drugs Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Dog Prescription Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Dog Prescription Drugs Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Dog Prescription Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Dog Prescription Drugs Sales Value (2021-2032) & (US$ Million) Figure 39. South America Dog Prescription Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Dog Prescription Drugs Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Dog Prescription Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Dog Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Dog Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Dog Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Dog Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Dog Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Dog Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Dog Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Dog Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Dog Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Dog Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Dog Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Dog Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Dog Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Dog Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Dog Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Dog Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Dog Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Dog Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Dog Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Dog Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Dog Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Dog Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Dog Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Dog Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Dog Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Dog Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Dog Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Dog Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Dog Prescription Drugs Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Dog Prescription Drugs Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Type
  • Spray Type
  • Smear Type
  • Injection Type
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Zoetis
  • Virbac
  • Vetoquinol
  • Ourofino Saude Animal
  • MSD Animal Health
  • Elanco Animal Health
  • Dechra
  • Ceva Sante Animale
  • Boehringer Ingelheim
  • Animalcare Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dog Prescription Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Dog Prescription Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Dog Prescription Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Dog Prescription Drugs Market Dynamics
  1. 2.1 Dog Prescription Drugs Industry Trends
  2. 2.2 Dog Prescription Drugs Industry Drivers
  3. 2.3 Dog Prescription Drugs Industry Opportunities and Challenges
  4. 2.4 Dog Prescription Drugs Industry Restraints
3 Dog Prescription Drugs Market by Company
  1. 3.1 Global Dog Prescription Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Dog Prescription Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Dog Prescription Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Dog Prescription Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Dog Prescription Drugs Company Ranking (2024-2026)
  6. 3.6 Global Dog Prescription Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Dog Prescription Drugs Company Product Type and Application
  8. 3.8 Global Dog Prescription Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Dog Prescription Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Dog Prescription Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Dog Prescription Drugs Market by Type
  1. 4.1 Dog Prescription Drugs Type Introduction
  2. 4.1.1 Oral Type
  3. 4.1.2 Spray Type
  4. 4.1.3 Smear Type
  5. 4.1.4 Injection Type
  6. 4.2 Global Dog Prescription Drugs Sales Volume by Type
  7. 4.2.1 Global Dog Prescription Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Dog Prescription Drugs Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Dog Prescription Drugs Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Dog Prescription Drugs Sales Value by Type
  11. 4.3.1 Global Dog Prescription Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Dog Prescription Drugs Sales Value by Type (2021-2032)
  13. 4.3.3 Global Dog Prescription Drugs Sales Value Share by Type (2021-2032)
5 Dog Prescription Drugs Market by Application
  1. 5.1 Dog Prescription Drugs Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Dog Prescription Drugs Sales Volume by Application
  6. 5.2.1 Global Dog Prescription Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dog Prescription Drugs Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Dog Prescription Drugs Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Dog Prescription Drugs Sales Value by Application
  10. 5.3.1 Global Dog Prescription Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Dog Prescription Drugs Sales Value by Application (2021-2032)
  12. 5.3.3 Global Dog Prescription Drugs Sales Value Share by Application (2021-2032)
6 Dog Prescription Drugs Regional Sales and Value Analysis
  1. 6.1 Global Dog Prescription Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dog Prescription Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Dog Prescription Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Dog Prescription Drugs Sales by Region (2027-2032)
  5. 6.3 Global Dog Prescription Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Dog Prescription Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Dog Prescription Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Dog Prescription Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Dog Prescription Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Dog Prescription Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Dog Prescription Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Dog Prescription Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Dog Prescription Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Dog Prescription Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Dog Prescription Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Dog Prescription Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Dog Prescription Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Dog Prescription Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Dog Prescription Drugs Sales Value Share by Country, 2025 VS 2032
7 Dog Prescription Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Dog Prescription Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Dog Prescription Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Dog Prescription Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Dog Prescription Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Dog Prescription Drugs Sales by Country (2027-2032)
  6. 7.4 Global Dog Prescription Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Dog Prescription Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Dog Prescription Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Dog Prescription Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Dog Prescription Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Dog Prescription Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Dog Prescription Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Dog Prescription Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Dog Prescription Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Dog Prescription Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Dog Prescription Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Dog Prescription Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Dog Prescription Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Dog Prescription Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Dog Prescription Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Dog Prescription Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Dog Prescription Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Dog Prescription Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Dog Prescription Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Dog Prescription Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Dog Prescription Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Dog Prescription Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Dog Prescription Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Dog Prescription Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Dog Prescription Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Dog Prescription Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Dog Prescription Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Dog Prescription Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Dog Prescription Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Dog Prescription Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Dog Prescription Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Dog Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Dog Prescription Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Dog Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Dog Prescription Drugs Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Virbac
  8. 8.2.1 Virbac Company Information
  9. 8.2.2 Virbac Business Overview
  10. 8.2.3 Virbac Dog Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Virbac Dog Prescription Drugs Product Portfolio
  12. 8.2.5 Virbac Recent Developments
  13. 8.3 Vetoquinol
  14. 8.3.1 Vetoquinol Company Information
  15. 8.3.2 Vetoquinol Business Overview
  16. 8.3.3 Vetoquinol Dog Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Vetoquinol Dog Prescription Drugs Product Portfolio
  18. 8.3.5 Vetoquinol Recent Developments
  19. 8.4 Ourofino Saude Animal
  20. 8.4.1 Ourofino Saude Animal Company Information
  21. 8.4.2 Ourofino Saude Animal Business Overview
  22. 8.4.3 Ourofino Saude Animal Dog Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Ourofino Saude Animal Dog Prescription Drugs Product Portfolio
  24. 8.4.5 Ourofino Saude Animal Recent Developments
  25. 8.5 MSD Animal Health
  26. 8.5.1 MSD Animal Health Company Information
  27. 8.5.2 MSD Animal Health Business Overview
  28. 8.5.3 MSD Animal Health Dog Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 MSD Animal Health Dog Prescription Drugs Product Portfolio
  30. 8.5.5 MSD Animal Health Recent Developments
  31. 8.6 Elanco Animal Health
  32. 8.6.1 Elanco Animal Health Company Information
  33. 8.6.2 Elanco Animal Health Business Overview
  34. 8.6.3 Elanco Animal Health Dog Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Elanco Animal Health Dog Prescription Drugs Product Portfolio
  36. 8.6.5 Elanco Animal Health Recent Developments
  37. 8.7 Dechra
  38. 8.7.1 Dechra Company Information
  39. 8.7.2 Dechra Business Overview
  40. 8.7.3 Dechra Dog Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Dechra Dog Prescription Drugs Product Portfolio
  42. 8.7.5 Dechra Recent Developments
  43. 8.8 Ceva Sante Animale
  44. 8.8.1 Ceva Sante Animale Company Information
  45. 8.8.2 Ceva Sante Animale Business Overview
  46. 8.8.3 Ceva Sante Animale Dog Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Ceva Sante Animale Dog Prescription Drugs Product Portfolio
  48. 8.8.5 Ceva Sante Animale Recent Developments
  49. 8.9 Boehringer Ingelheim
  50. 8.9.1 Boehringer Ingelheim Company Information
  51. 8.9.2 Boehringer Ingelheim Business Overview
  52. 8.9.3 Boehringer Ingelheim Dog Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Boehringer Ingelheim Dog Prescription Drugs Product Portfolio
  54. 8.9.5 Boehringer Ingelheim Recent Developments
  55. 8.10 Animalcare Group
  56. 8.10.1 Animalcare Group Company Information
  57. 8.10.2 Animalcare Group Business Overview
  58. 8.10.3 Animalcare Group Dog Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Animalcare Group Dog Prescription Drugs Product Portfolio
  60. 8.10.5 Animalcare Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dog Prescription Drugs Value Chain Analysis
  2. 9.1.1 Dog Prescription Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dog Prescription Drugs Sales Mode & Process
  6. 9.2 Dog Prescription Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dog Prescription Drugs Distributors
  9. 9.2.3 Dog Prescription Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst